Inventor · disambiguated record
Tim Beissert
Also filed as: BEISSERT TIM
11 granted patents·14 pending applications·15 citations·filing 2008–2025
84Inventor score
Files withBioNTech SE9BIONTECH AG7BIONTECH RNA PHARMACEUTICALS GMBH3BIONTECH CELL & GENE THERAPIES GMBH2SAHIN UGUR2
Top patents by PatentIndex Score
25 records- 0190US10717780B2Agents for treatment of claudin expressing cancer diseasesBIONTECH AG·Filed 2018·Granted Jul 21, 2020·5 cites·12 claims
- 0284US10093736B2Agents for treatment of claudin expressing cancer diseasesBIONTECH AG·Filed 2013·Granted Oct 9, 2018·7 cites·9 claims
- 0376US11168337B2RNA replicon for versatile and efficient gene expressionBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2017·Granted Nov 9, 2021·1 cites·23 claims
- 0475US12378531B2Use of RNA for reprogramming somatic cellsBioNTech SE·Filed 2021·Granted Aug 5, 2025·0 cites·9 claims
- 0574US2024228616A1Agents for Treatment of Claudin Expressing Cancer DiseasesBIONTECH AG·Filed 2022·Application pending·0 cites
- 0671US11492628B23′-UTR sequences for stabilization of RNABioNTech SE·Filed 2016·Granted Nov 8, 2022·1 cites·73 claims
- 0771US11008550B2Use of RNA for reprogramming somatic cellsBIONTECH AG·Filed 2019·Granted May 18, 2021·0 cites·4 claims
- 0870US2024287155A1Rna replicon for expressing at cell receptor or an artificial t cell receptorBIONTECH CELL & GENE THERAPIES GMBH·Filed 2023·Application pending·0 cites
- 0969US12281322B2RNA replicon for versatile and efficient gene expressionBioNTech SE·Filed 2021·Granted Apr 22, 2025·0 cites·13 claims
- 1069US2025290095A1Trans-Replicating RNABioNTech SE·Filed 2025·Application pending·0 cites
- 1165US2020399370A1Agents for Treatment of Claudin Expressing Cancer DiseasesBIONTECH AG·Filed 2020·Application pending·0 cites
- 1264US2011065103A1Use of rna for reprogramming somatic cellsSAHIN UGUR·Filed 2008·Application pending·0 cites
- 1361US10207009B2Method for cellular RNA expressionTRON TRANSLATIONALE ONKOLOGIE AN DER UNIV DER JOHANNES GUTENBE·Filed 2015·Granted Feb 19, 2019·1 cites·33 claims
- 1460US2025236883A1Modified replicable rna and related compositions and their useBioNTech SE·Filed 2022·Application pending·0 cites
- 1560US2025281602A1Replicon Compositions and Methods of Using Same for the Treatment of DiseasesBioNTech SE·Filed 2023·Application pending·0 cites
- 1657US12338448B2Trans-replicating RNABioNTech SE·Filed 2017·Granted Jun 24, 2025·0 cites·19 claims
- 1757US2017218342A1Use of rna for reprogramming somatic cellsBIONTECH AG·Filed 2017·Application pending·0 cites
- 1857US2025250626A1Methods for determining mutations for increasing modified replicable rna function and related compositions and their useBioNTech SE·Filed 2022·Application pending·0 cites
- 1955US10729784B2Method for cellular RNA expressionTRON TRANSLATIONALE ONKOLOGIE AN DER UNIV DER JOHANNES GUTENBERG UNIV MAINZ GGMBH·Filed 2019·Granted Aug 4, 2020·0 cites·19 claims
- 2055US2020283497A1Rna replicon for expressing at cell receptor or an artificial t cell receptorBIONTECH CELL & GENE THERAPIES GMBH·Filed 2018·Application pending·0 cites
- 2153US2016122721A1Use of rna for reprogramming somatic cellsBIONTECH AG·Filed 2015·Application pending·0 cites
- 2252US2023265454A1RNA Replicon for Versatile and Efficient Gene ExpressionBioNTech SE·Filed 2021·Application pending·0 cites
- 2346US12291717B2RNA replicon for reprogramming somatic cellsBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2018·Granted May 6, 2025·0 cites·19 claims
- 2443US2020362313A1Method of enhancing rna expression in a cellBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2018·Application pending·0 cites
- 2538US2014030808A1Method for Cellular RNA ExpressionSAHIN UGUR·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tim Beissert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →